ARTICLE | Clinical News
VP 50406: Phase IIa update
November 19, 2001 8:00 AM UTC
ViroPharma Inc. (VPHM), Exton, Penn. Product: VP 50406 Business: Infectious diseases Therapeutic category: Viral infection Target: HCV Description: Small molecule HCV inhibitor Indication: Treat hepat...